Overgrowth Syndromes. MichaelCohenJr.GiovanniNeriRosannaWeksberg2002Oxford University PressNew York206$85.  by Olney, Ann Haskins
772
Book Reviews
Am. J. Hum. Genet. 72:772–773, 2003
Overgrowth Syndromes. By Michael Cohen, Jr.; Giovanni
Neri; and Rosanna Weksberg. New York: Oxford
University Press, 2002. Pp. 206. $85.
This timely, intriguing volume represents the collaborative ef-
forts of three individuals at the forefront of overgrowth syn-
drome study: Dr. M. Michael Cohen, Jr.; Dr. Giovanni Neri;
and Dr. Rosanna Weksberg. The book discusses a group of
disorders resulting in large size at birth, excessive postnatal
growth, or some combination of increased weight, increased
length, and/or increased head circumference. In a number of
these syndromes, there is not only somatic overgrowth but
also a risk of neoplasia. With an increasing number of rec-
ognized overgrowth syndromes and significant recent advances
in our understanding of the molecular mechanisms producing
overgrowth, this is a welcome publication. Comprehensive
works addressing this complex group of disorders have not
previously existed.
As Dr. J. Bruce Beckwith notes in his insightful foreword to
the book, new discoveries of the molecular processes at work
in overgrowth syndromes, such as genomic imprinting in Beck-
with-Wiedemann syndrome, have contributed to the recognition
of similar processes in tumor growth. This book comprehen-
sively couples detailed clinical information on overgrowth syn-
dromes with current knowledge of their molecular biology. In
spite of the complexity of the underlying molecular mechanisms
of many of these syndromes, the authors have created a highly
readable text which provides thorough, clearly presented ex-
planations of their pathogenesis.
After an introductory overview, the next 12 chapters of the
book are each devoted to one of the well-recognized overgrowth
syndromes: Beckwith-Wiedemann syndrome; hemihyperplasia;
Simpson-Golabi-Behmel syndrome; Perlman syndrome; Sotos
syndrome; Weaver syndrome; Bannayan-Riley-Ruvalcaba syn-
drome; Proteus syndrome; Klippel-Trenaunay, Parkes Weber,
and Sturge-Weber syndromes; Maffucci syndrome; neurofibro-
matosis; and fragile X syndrome. Additional chapters summa-
rize chromosomal disorders with overgrowth, maternal and en-
docrine effects, nonsyndromal overgrowth, fetal hydrops, and
other syndromes and conditions with overgrowth.
The organization of each chapter differs slightly, depending
on the state of knowledge for each syndrome. Most chapters
contain sections providing a historical perspective, epidemi-
ology, etiology and molecular biology when known, growth
and skeletal findings, clinical phenotype, diagnostic criteria,
associated neoplasms, diagnostic studies, and differential di-
agnosis. When available, estimates of birth prevalence, growth
curves, and final height attainment for the syndrome are in-
cluded; this is certainly useful information not easily found
elsewhere. Susceptibility to specific tumors, a key finding in
many of the diverse conditions causing overgrowth, is high-
lighted throughout the book. The differential diagnoses are
masterfully done and will be of great benefit to practitioners.
They are both inclusive in syndromes listed and succinct in
discussion of distinguishing features.
I found several chapters particularly well done. The Beck-
with-Wiedemann syndrome chapter contains an excellent, un-
derstandable review of the complex genetic and epigenetic fac-
tors involved, as well as useful guidelines on postnatal patient
evaluation. The exhaustive chapter on Proteus syndrome in-
cludes fascinating historical information and very detailed list-
ings of uncommon and unusual clinical findings and neoplasms.
The chapter on Klippel-Trenaunay, Parkes Weber, and Sturge-
Weber syndromes is very helpful in clarifying terminology and
in the classification of these disorders. The chapter onmaternal
and endocrine effects contains excellent discussions of infants
of diabetic mothers and persistent hyperinsulinemic hypogly-
cemia of infancy, along with the interesting section on infants
of psoriatic mothers. Included in the chapter, “Chromosomal
Disorders and Overgrowth,” are descriptions of Pallister-Killian
syndrome (mosaic tetrasomy 12p) and several other chro-
mosomal duplications and deletions. The chapter entitled,
“Other Syndromes,” includes several relatively rare but im-
portant conditions: Costello syndrome, macrocephaly-cutis
marmorata syndrome, Cantu´ syndrome, Nevo syndrome, and
Elejalde syndrome. The final chapter, “Miscellaneous Syn-
dromes and Conditions with Overgrowth,” provides brief, in-
formative reviews of over 20 conditions, including some in
which only a subset of patients show overgrowth.
Appearing throughout the book are the wonderful, highly
detailed tables that are Dr. Cohen’s trademark, some newly
created and some carefully updated and adapted from previous
publications. These useful tabular summaries permit ready ac-
cess to an enormous volume of clinical information. Tables sum-
marizing the types of tumors reported in each condition and
the frequencies of their occurrence will be especially helpful
to clinicians. The diagrammatic representations of molecular
processes are very well done, notably those illustrating im-
printing in Dr. Weksberg’s chapter on Beckwith-Wiedemann
syndrome, the putative role of GPC3 in Dr. Neri’s chapter on
Simpson-Golabi-Behmel syndrome, and the working model of
the PTEN regulatory network in Dr. Cohen’s chapter on Ban-
nayan-Riley-Ruvalcaba syndrome. Most chapters feature out-
standing illustrations of pathological findings. Excellent pa-
tient photographs appear in every chapter; particularly helpful
are the photographs demonstrating the evolution of the facial
phenotype in Beckwith-Wiedemann syndrome and the exten-
sive photographic illustrations of Proteus syndrome.
Each chapter is very thoroughly referenced; the book contains
over 1,000 references. The writing is excellent, interspersedwith
practical comments, pearls of wisdom, and occasionalwitticisms
from the authors, making the book both enjoyable to read and
exceedingly applicable in practice.
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Overgrowth Syndromes is a unique, landmark book packed
with information, compiled in expert fashion by these well-rec-
ognized authors. It will be an essential addition to the libraries
of medical geneticists and dysmorphologists and a valuable
resource for pediatricians, oncologists, hematologists, pediatric
endocrinologists, pathologists, surgeons, dermatologists, ne-
phrologists, radiologists, and molecular biologists.
ANN HASKINS OLNEY
Munroe-Meyer Institute for Genetics and
Rehabilitation and Department of Pediatrics
University of Nebraska Medical Center
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Genes and Mechanisms in Vertebrate Sex Determination.
Edited by G. Scherer and M. Schmid. Basel: Birkha¨user
Verlag, 2001. Pp. 205. $109.
The Genetics and Biology of Sex Determination. Novartis
Foundation Symposium 244. Chichester: John Wiley and
Sons, 2002. Pp. 265. $125.
What is uniquely valuable about these books that would make
it worth owning, or at least reading, both? Those with a strong
interest in that area of developmental biology pertaining to
the evolution, genetics, endocrinology, development, and clin-
ical aspects of sex determination and sex differentiation will
find that, in spite of considerable overlap, these volumes com-
plement each other in may ways, each bringing exceptionally
valuable contributions. The Wiley book is, in all respects, a
later and more up-to-date treatment.
The Birkha¨user volume consists of “updated and revised
versions” of a series of articles published in the multiauthor
review of Genes and Mechanisms in Vertebrate Sex Deter-
mination in Cellular and Molecular Life Sciences (1999, 55:
821–931). Susumu Ohno’s final illness precluded revision of
his paper; the review by Schmid and Steinlein is new. The
editors are well known: Schmid (Wu¨rzburg), for his work in
amphibian sex determination and sex differentiation, and
Scherer (Freiburg), for his contributions to SOX9 and the cam-
pomelic syndrome. The book is dedicated to Ohno, “whose
contributions to the field of vertebrate sex determination have
stimulated and inspired research in this field over many years.”
In addition to the preface, the book contains nine reviews:
Ohno, “The One-to-Four Rule and Paralogues of Sex-Deter-
mining Genes”; Parker, Schimmer, and Schedl, “Genes Essen-
tial for Early Events in Gonadal Development”; Koopman,
“Sry, Sox9 and Mammalian Sex Determination”; Goodfellow
and Camerino, “DAX-1, an ‘Antitestis’ Gene”; Pask and
Graves, “Sex Chromosomes and Sex Determining Genes: In-
sights from Marsupials and Monotremes”; Clinton and
Haines, “An Overview of Factors Influencing Sex Determi-
nation and Gonadal Development”; Pieau, Dorizzi, and Rich-
ard-Mercier, “Temperature-Dependent Sex Determination and
Gonadal Differentiation in Reptiles”; Schmid and Steinlein,
Sex Chromosomes, Sex-Linked Genes, and Sex Determination
in the Vertebrate Class Amphibia”; and Baroiller and Guiguen,
“Endocrine and Environmental Aspects of Sex Differentiation
in Gonochoristic Fish.”
In his review, Ohno was able to bring concrete evidence for
his hypothesis, advanced in 1970, that gnathostomes “under-
went two successive rounds of tetraploidization at their in-
ception”; that is, that vertebrates are the octoploid descendants
of an ancestor with a much simpler genome—hence, for ex-
ample, our four paralogous Hox groups compared with the
single Hox cluster in Drosophila, with a similar situation in
the Notch, Mef2, Ras, Egrl/Krox20, Gli, Src, Scr-related, and
Jak genes; the nuclear receptor family; and Sox genes.
Ohno, for one, was impressed by the antiquity of SRY,
thought that it was worthwhile looking for its ancestor among
the invertebrates, and concluded that it was not closely related
to Sox3. For an answer and update, one must go to the Graves
review in the Novartis volume (pp. 86–111, with discussion
to p. 114). She concurs that SRY arose from (the X-linked)
Sox3 or SRX gene rather recently, since it is present only in
mammals and marsupials and not in nonmammalian verte-
brates (the monotremes).
In the Birkha¨user volume, the Sry and Sox9 story is told in
detail by Peter Koopman, with over 200 references, and will
remain the definitive review of that subject for a long time.
Peter Goodfellow and Giovanna Camerino review their
work and that of others on DAX-1, the antitestis gene, and
point out the differences in function of that gene in mice and
humans; absence of DAX-1 in humans leading to congenital
adrenal insufficiency and hypogonadotrophic hypogonadism;
and, in mice, associated with normal gonadotropin levels. The
concept of an antitestis effect of DAX-1 in the development
of the ovary recalls the pioneering concept of Witschi of cor-
ticomedullary antagonism (“anticorticin” and “antimedul-
larin”) during gonadal differentiation. Indeed, most of Wit-
schi’s work is severely neglected by recent workers in the field,
including the very idea that the initial gonad of vertebrates is
bipotential, with cortex becoming ovary in females and me-
dulla becoming testis in males.
The review by Andrew Pask and Jennifer Marshall Graves
on the marsupial and monotreme sex chromosomes and sex-
determining genes is a lovely introduction updated and am-
plified by Graves in the Novartis volume (pp. 86–110).
Clinicians may think that the rest of the reviews in the Birk-
ha¨user volume on birds, reptiles, amphibians, and fish can be
safely ignored because of lack of pertinence to clinical practice.
Such a narrow view would deprive the reader so inclined of
a huge amount of intellectual pleasure, a chance to reaffirm
the perspective—no, the fact—that everything that develops
has evolved and of some amazing comparative insights of di-
rect clinical relevance. The most interesting of these, at least
to this reader, is the del(9p) story. In males, such deletions may
lead to male pseudohermaphroditism caused by deletion of the
DMRT1 gene—to date, the only sex-determining gene known
